NeuroGenesis Bio
Biotechnology Research • 
Brighton, New York, United States • 11-20 Employees
Company overview
| Headquarters | 410 White Spruce Blvd, Rochester, New York 14623, US |
| Website | |
| NAICS | 541714 |
| Keywords | Biotech, Neurodegenerative Diseases, Cell Therapies |
| Founded | 2018 |
| Employees | 11-20 |
| Socials |
Key Contacts at NeuroGenesis Bio
Tal Gilat
Founder & Ceo
Moshe Hukaylo
Director Of Finance
NeuroGenesis Bio Email Formats
NeuroGenesis Bio uses 1 email format. The most common is {first initial} (e.g., j@neurogenesis-cell.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@neurogenesis-cell.com | 100% |
About NeuroGenesis Bio
NeuroGenesis Bio Inc. is a clinical-stage cellular therapy company focused on developing novel and effective treatments for neurodegenerative diseases. The company has developed NG01 as a proprietary method to transform a unique subpopulation of marrow-derived cells into bio-factories for sustained delivery of regenerative and neuroprotective proteins. By promoting myelin and neuronal regeneration, the NG01 cellular therapy platform is optimized to treat neurodegenerative diseases such as progressive multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS). NG01 has been studied extensively in several clinical trials including a successful double blind, randomized, placebo-controlled Phase II study for progressive MS, and two long term (up to 4 years) Phase IIa trials for Progressive MS and ALS. To date, more than 160 progressive MS and ALS patients from around the world have been treated with this breakthrough therapeutic modality. Headquartered in Upstate NY, NeuroGenesis is steadily moving forward with a global, FDA-approved multi-site Phase IIb trial for secondary progressive multiple sclerosis, in partnership with major medical research centers in the United States and abroad. For more information on the company, please visit: https://neurogenesis-cell.com/
NeuroGenesis Bio revenue & valuation
| Annual revenue | $1,026,660 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $3,300,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
NeuroGenesis Bio has 6 employees across 5 departments.
Departments
Number of employees
NeuroGenesis Bio Tech Stack
Discover the technologies and tools that power NeuroGenesis Bio's digital infrastructure, from frameworks to analytics platforms.
Security
Caching
JavaScript libraries
Page builders
JavaScript libraries
CDN
JavaScript libraries
Miscellaneous
Programming languages
Blogs
Analytics
Finland
Italy
AustraliaFrequently asked questions
4.8
40,000 users
